Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer

被引：0

作者：

Schmidt, M. ^{[1
]}

Jackisch, C. ^{[2
]}

Hesse, T. ^{[3
]}

Hoffmann, O. ^{[4
]}

Heinrich, B. J. ^{[5
]}

Park-Simon, T-W ^{[6
]}

Grischke, E-M. ^{[7
]}

Weide, R. ^{[8
]}

Mueller-Huesmann, H. ^{[9
]}

Welslau, M. ^{[10
]}

Wu, J. ^{[11
]}

Schmitz, H. ^{[12
]}

Engelbrecht, C. ^{[13
]}

Lueck, H-J. ^{[14
]}

机构：

[1] Univ Klinkum Mainz, Dept Gynecol, Mainz, Germany

[2] Sana Klinikum Offenbach GmbH, Dept Obstet & Gynecol, Offenbach, Germany

[3] Agaples Diakonieklinikum Rotenburg gGmbH, Dept Gynecol, Rotenburg, Germany

[4] Univ Klinikum Essen, Dept Gynecol & Obstet, Essen, Germany

[5] Praxis Heinrich Bangerter, Hematol Oncol, Augsburg, Germany

[6] MHH Hannover, Dept Gynecol, Hannover, Germany

[7] Univ Frauenklin Tubingen, Oncol, Tubingen, Germany

[8] Praxis Hamatol & Onkol Koblenz, Oncol Outpatient Dept, Koblenz, Germany

[9] Bruderkrankenhaus St Josef Paderborn, Dept Hematol Oncol, Paderborn, Germany

[10] Klinikum Aschaffenburg, Hematol Oncol, Aschaffenburg, Germany

[11] Eisai Inc, Biostat, Woodcliff Lake, NJ USA

[12] Eisai GmbH, Dept Med, Frankfurt, Germany

[13] Eisai GmbH, Med Affairs, Frankfurt, Germany

[14] Gynakol Onkol Praxis Pelikanpl, Gynecol Oncol, Hannover, Germany

来源：

ANNALS OF ONCOLOGY | 2021年 / 32卷

关键词：

D O I：

10.1016/j.annonc.2021.08.587

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

304P

引用

页码：S496 / S497

页数：2

共 50 条

[31] Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
Junichiro Watanabe
Yoshinori Ito
Shozo Ohsumi
Mitsuhiro Mizutani
Hideya Tashiro
Kenichi Sakurai
Masato Takahashi
Tsuyoshi Saito
Junji Tsurutani
Hirofumi Mukai
Tetsuhiro Yoshinami
Shintaro Takao
Yasuhisa Yamamoto
Toshiyuki Matsuoka
Hirotaka Iwase
Hiroji Iwata
Seigo Nakamura
Toshiaki Saeki
Investigational New Drugs, 2017, 35 : 791 - 799
[32] Incidence of peripheral neuropathy associated with eribulin mesylate versus vinorelbine in patients with metastatic breast cancer: sub-group analysis of a randomized phase III study
Wu, Ying
Wang, Qin
Zhang, Jian
Cao, Jun
Wang, Biyun
Hu, Xichun
SUPPORTIVE CARE IN CANCER, 2020, 28 (08) : 3819 - 3829
[33] Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
Watanabe, Junichiro
Ito, Yoshinori
Ohsumi, Shozo
Mizutani, Mitsuhiro
Tashiro, Hideya
Sakurai, Kenichi
Takahashi, Masato
Saito, Tsuyoshi
Tsurutani, Junji
Mukai, Hirofumi
Yoshinami, Tetsuhiro
Takao, Shintaro
Yamamoto, Yasuhisa
Matsuoka, Toshiyuki
Iwase, Hirotaka
Iwata, Hiroji
Nakamura, Seigo
Saeki, Toshiaki
INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 791 - 799
[34] Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
Sakura Iizumi
Tatsunori Shimoi
Natsuko Tsushita
Seiko Bun
Akihiko Shimomura
Emi Noguchi
Makoto Kodaira
Mayu Yunokawa
Kan Yonemori
Chikako Shimizu
Yasuhiro Fujiwara
Kenji Tamura
BMC Cancer, 17
[35] Effects of dose modification of eribulin mesylate in patients with locally recurrent or metastatic breast cancer
Faria, Claudio
Li, Xuan
Powers, Annette
Vahdat, Linda T.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
[36] Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
Iizumi, Sakura
Shimoi, Tatsunori
Tsushita, Natsuko
Bun, Seiko
Shimomura, Akihiko
Noguchi, Emi
Kodaira, Makoto
Yunokawa, Mayu
Yonemori, Kan
Shimizu, Chikako
Fujiwara, Yasuhiro
Tamura, Kenji
BMC CANCER, 2017, 17
[37] Incidence of peripheral neuropathy associated with eribulin mesylate versus vinorelbine in patients with metastatic breast cancer: sub-group analysis of a randomized phase III study
Ying Wu
Qin Wang
Jian Zhang
Jun Cao
Biyun Wang
Xichun Hu
Supportive Care in Cancer, 2020, 28 : 3819 - 3829
[38] HALAVEN ® (Eribulin) as an intelligent Therapy Option for Patients with advanced and/or metastatic Breast Cancer
不详
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) : 338 - 338
[39] Incidence and relative risk of peripheral neuropathy in cancer patients treated with eribulin: a meta-analysis
Peng, Ling
Hong, Yun
Ye, Xianghua
Shi, Peng
Zhang, Junyan
Wang, Yina
Zhao, Qiong
ONCOTARGET, 2017, 8 (67) : 112076 - 112084
[40] Locally advanced and metastatic breast cancer
Rubens, RD
EUROPEAN JOURNAL OF CANCER, 1998, 34 : S10 - S10

← 1 2 3 4 5 →